Results 151 to 160 of about 163,250 (350)
In ESCC patients, SNORA58 exhibits heterogeneous expression patterns. Its aberrant overexpression stabilizes CTCF by inhibiting ubiquitin‐mediated degradation, leading to the attenuation of JNK1‐mediated ferroptosis induced by radiotherapy through disruption of intracellular iron homeostasis, and ultimately contributes to radioresistance ...
Yinli Zheng+14 more
wiley +1 more source
Increasing Rates of Esophageal Stricture and Dilation Over 2 Decades in Eosinophilic Esophagitis
S.B. Greenberg+11 more
doaj
Background & Aims: Microbial molecular products incite intestinal inflammation by activating Toll-like receptors (TLRs) and inflammasomes of the innate immune system. This systemâs contribution to esophageal inflammation is not known.
Yuji Nadatani+14 more
doaj
Prediction of left anterior descending coronary artery disease by esophageal echocardiography.
Kazuhide Fukagawa
openalex +2 more sources
B‐cell lymphomas are aggressive malignancies with limited treatment options. A bispecific nanosystem (biHSNPs) is developed, leveraging silica nanoplatforms to conjugate antibodies targeting immune effector cells and B‐cell antigens. biHSNPs form artificial immunological synapses, activating cytotoxic responses and suppressing tumor proliferation. This
Yefeng Shen+12 more
wiley +1 more source
A Case of Behçet's Disease with Esophageal Ulcer
Hirofumi MIYAMOTO+8 more
openalex +2 more sources
This study develops the hydrogel with antimicrobial, adhesive, degradable, injectable, and temperature‐sensitive contraction properties based on the transcriptomic and pathological characteristics of intestinal fistula patients. This hydrogel can seal rabbit intestinal fistula in situ, reduce the intestinal defect, and promote intestinal epithelial ...
Ze Li+12 more
wiley +1 more source
Exploring Esophageal Microbiomes in Esophageal Diseases: A Systematic Review. [PDF]
Park CH, Lee SK.
europepmc +1 more source
Successful treatment of esophageal Crohn's disease with infliximab [PDF]
D Fefferman
openalex +1 more source
This retrospective study suggests that gastrectomy is a risk factor for choledocholithiasis. Especially in terms of the differences in reconstruction methods, the median time from gastrectomy to development of choledocholithiasis was 5.5 years for Roux‐en‐Y, which was significantly faster than 20 years for Billroth I and 35 years for Billroth II ...
Yuki Matsui+8 more
wiley +1 more source